Asset Details
Do you wish to reserve the book?
Evaluating the reliability of neurocognitive biomarkers of neurodegenerative diseases across countries: A machine learning approach
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Evaluating the reliability of neurocognitive biomarkers of neurodegenerative diseases across countries: A machine learning approach
Do you wish to request the book?
Evaluating the reliability of neurocognitive biomarkers of neurodegenerative diseases across countries: A machine learning approach
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Evaluating the reliability of neurocognitive biomarkers of neurodegenerative diseases across countries: A machine learning approach
2020
Overview
Accurate early diagnosis of neurodegenerative diseases represents a growing challenge for current clinical practice. Promisingly, current tools can be complemented by computational decision-support methods to objectively analyze multidimensional measures and increase diagnostic confidence. Yet, widespread application of these tools cannot be recommended unless they are proven to perform consistently and reproducibly across samples from different countries. We implemented machine-learning algorithms to evaluate the prediction power of neurocognitive biomarkers (behavioral and imaging measures) for classifying two neurodegenerative conditions –Alzheimer Disease (AD) and behavioral variant frontotemporal dementia (bvFTD)– across three different countries (>200 participants). We use machine-learning tools integrating multimodal measures such as cognitive scores (executive functions and cognitive screening) and brain atrophy volume (voxel based morphometry from fronto-temporo-insular regions in bvFTD, and temporo-parietal regions in AD) to identify the most relevant features in predicting the incidence of the diseases. In the Country-1 cohort, predictions of AD and bvFTD became maximally improved upon inclusion of cognitive screenings outcomes combined with atrophy levels. Multimodal training data from this cohort allowed predicting both AD and bvFTD in the other two novel datasets from other countries with high accuracy (>90%), demonstrating the robustness of the approach as well as the differential specificity and reliability of behavioral and neural markers for each condition. In sum, this is the first study, across centers and countries, to validate the predictive power of cognitive signatures combined with atrophy levels for contrastive neurodegenerative conditions, validating a benchmark for future assessments of reliability and reproducibility.
Publisher
Elsevier Inc,Elsevier Limited,Elsevier
Subject
/ Aged
/ Alzheimer Disease - diagnosis
/ Alzheimer Disease - pathology
/ Alzheimer Disease - physiopathology
/ Atrophy
/ Dementia
/ Disease
/ Executive Function - physiology
/ Female
/ Frontotemporal Dementia - diagnosis
/ Frontotemporal Dementia - pathology
/ Frontotemporal Dementia - physiopathology
/ Humans
/ Male
/ Patients
